These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 18307044)

  • 1. Human osteoclasts differentiated from umbilical cord blood precursors are less prone to apoptotic stimuli than osteoclasts from peripheral blood.
    Penolazzi L; Pocaterra B; Tavanti E; Lambertini E; Vesce F; Gambari R; Piva R
    Apoptosis; 2008 Apr; 13(4):553-61. PubMed ID: 18307044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apoptosis of human primary osteoclasts treated with molecules targeting nuclear factor-kappaB.
    Piva R; Penolazzi L; Borgatti M; Lampronti I; Lambertini E; Torreggiani E; Gambari R
    Ann N Y Acad Sci; 2009 Aug; 1171():448-56. PubMed ID: 19723088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human microvascular endothelial cell activation by IL-1 and TNF-alpha stimulates the adhesion and transendothelial migration of circulating human CD14+ monocytes that develop with RANKL into functional osteoclasts.
    Kindle L; Rothe L; Kriss M; Osdoby P; Collin-Osdoby P
    J Bone Miner Res; 2006 Feb; 21(2):193-206. PubMed ID: 16418775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receptor activator of nuclear factor kappa B ligand (RANKL) modulates the expression of genes involved in apoptosis and cell cycle in human osteoclasts.
    Rimondi E; Zweyer M; Ricci E; Fadda R; Secchiero P
    Anat Rec (Hoboken); 2007 Jul; 290(7):838-45. PubMed ID: 17506059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GM-CSF regulates fusion of mononuclear osteoclasts into bone-resorbing osteoclasts by activating the Ras/ERK pathway.
    Lee MS; Kim HS; Yeon JT; Choi SW; Chun CH; Kwak HB; Oh J
    J Immunol; 2009 Sep; 183(5):3390-9. PubMed ID: 19641137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteoclast culture and resorption assays.
    Bradley EW; Oursler MJ
    Methods Mol Biol; 2008; 455():19-35. PubMed ID: 18463808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aldehydic components of cinnamon bark extract suppresses RANKL-induced osteoclastogenesis through NFATc1 downregulation.
    Tsuji-Naito K
    Bioorg Med Chem; 2008 Oct; 16(20):9176-83. PubMed ID: 18823786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Baicalein inhibits osteoclast differentiation and induces mature osteoclast apoptosis.
    Kim MH; Ryu SY; Bae MA; Choi JS; Min YK; Kim SH
    Food Chem Toxicol; 2008 Nov; 46(11):3375-82. PubMed ID: 18786594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reveromycin A, an agent for osteoporosis, inhibits bone resorption by inducing apoptosis specifically in osteoclasts.
    Woo JT; Kawatani M; Kato M; Shinki T; Yonezawa T; Kanoh N; Nakagawa H; Takami M; Lee KH; Stern PH; Nagai K; Osada H
    Proc Natl Acad Sci U S A; 2006 Mar; 103(12):4729-34. PubMed ID: 16537392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of apoptosis of human primary osteoclasts treated with a transcription factor decoy mimicking a promoter region of estrogen receptor alpha.
    Piva R; Penolazzi L; Lambertini E; Giordano S; Gambari R
    Apoptosis; 2005 Oct; 10(5):1079-94. PubMed ID: 16151641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of apoptosis of osteoclasts by targeting transcription factors with decoy molecules.
    Piva R; Penolazzi L; Zennaro M; Bianchini E; Magri E; Borgatti M; Lampronti I; Lambertini E; Tavanti E; Gambari R
    Ann N Y Acad Sci; 2006 Dec; 1091():509-16. PubMed ID: 17341640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bavachalcone inhibits osteoclast differentiation through suppression of NFATc1 induction by RANKL.
    Park CK; Lee Y; Chang EJ; Lee MH; Yoon JH; Ryu JH; Kim HH
    Biochem Pharmacol; 2008 Jun; 75(11):2175-82. PubMed ID: 18433733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen prevents bone loss via estrogen receptor alpha and induction of Fas ligand in osteoclasts.
    Nakamura T; Imai Y; Matsumoto T; Sato S; Takeuchi K; Igarashi K; Harada Y; Azuma Y; Krust A; Yamamoto Y; Nishina H; Takeda S; Takayanagi H; Metzger D; Kanno J; Takaoka K; Martin TJ; Chambon P; Kato S
    Cell; 2007 Sep; 130(5):811-23. PubMed ID: 17803905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibility to Fas and tumor necrosis factor-alpha receptor mediated apoptosis of anti-CD3/anti-CD28-activated umbilical cord blood T cells.
    Lin SJ; Lee CC; Cheng PJ; See LC; Kuo ML
    Pediatr Allergy Immunol; 2009 Jun; 20(4):392-8. PubMed ID: 18713315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidermal growth factor receptor regulates osteoclast differentiation and survival through cross-talking with RANK signaling.
    Yi T; Lee HL; Cha JH; Ko SI; Kim HJ; Shin HI; Woo KM; Ryoo HM; Kim GS; Baek JH
    J Cell Physiol; 2008 Nov; 217(2):409-22. PubMed ID: 18543257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ca2+-NFATc1 signaling is an essential axis of osteoclast differentiation.
    Negishi-Koga T; Takayanagi H
    Immunol Rev; 2009 Sep; 231(1):241-56. PubMed ID: 19754901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Caffeic acid phenethyl ester inhibits osteoclastogenesis by suppressing NF kappaB and downregulating NFATc1 and c-Fos.
    Ha J; Choi HS; Lee Y; Lee ZH; Kim HH
    Int Immunopharmacol; 2009 Jun; 9(6):774-80. PubMed ID: 19285574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Optimized Method to Generate Human Active Osteoclasts From Peripheral Blood Monocytes.
    Abdallah D; Jourdain ML; Braux J; Guillaume C; Gangloff SC; Jacquot J; Velard F
    Front Immunol; 2018; 9():632. PubMed ID: 29670619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of NFAT binding sites that mediate stimulation of cathepsin K promoter activity by RANK ligand.
    Balkan W; Martinez AF; Fernandez I; Rodriguez MA; Pang M; Troen BR
    Gene; 2009 Oct; 446(2):90-8. PubMed ID: 19563866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of estrogen receptor alpha expression with decoy oligonucleotide targeted to NFATc1 binding sites in osteoblasts.
    Penolazzi L; Zennaro M; Lambertini E; Tavanti E; Torreggiani E; Gambari R; Piva R
    Mol Pharmacol; 2007 Jun; 71(6):1457-62. PubMed ID: 17389747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.